Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AC Immune (ACIU) Profit After Tax: 2014-2024

Historic Profit After Tax for AC Immune (ACIU) over the last 11 years, with Dec 2024 value amounting to -$58.1 million.

  • AC Immune's Profit After Tax fell 412.11% to -$19.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$94.5 million, marking a year-over-year decrease of 198.11%. This contributed to the annual value of -$58.1 million for FY2024, which is 4.94% up from last year.
  • Per AC Immune's latest filing, its Profit After Tax stood at -$58.1 million for FY2024, which was up 4.94% from -$61.1 million recorded in FY2023.
  • Over the past 5 years, AC Immune's Profit After Tax peaked at -$58.1 million during FY2024, and registered a low of -$79.9 million during FY2021.
  • Moreover, its 3-year median value for Profit After Tax was -$61.1 million (2023), whereas its average is -$64.2 million.
  • In the last 5 years, AC Immune's Profit After Tax tumbled by 249.18% in 2020 and then increased by 16.75% in 2023.
  • AC Immune's Profit After Tax (Yearly) stood at -$68.5 million in 2020, then declined by 16.63% to -$79.9 million in 2021, then increased by 8.06% to -$73.4 million in 2022, then grew by 16.75% to -$61.1 million in 2023, then climbed by 4.94% to -$58.1 million in 2024.